Daidzein improves insulin resistance in ovariectomized rats

References

• Carr MC. The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab 2003;88:2404–11
   PubMed Web of Science ®Google Scholar
• Kim HM, Park J, Ryu SY, Kim J. The effect of menopause on the metabolic syndrome among Korean women: the Korean National Health and Nutrition Examination Survey, 2001. Diabetes Care 2007;30:701–6
   PubMed Web of Science ®Google Scholar
• Cho GJ, Lee JH, Park HT, Postmenopausal status according to years since menopause as an independent risk factor for the metabolic syndrome. Menopause 2008;15:524–9
   PubMed Web of Science ®Google Scholar
• Lin KC, Tsai ST, Kuo SC, Tsay SL, Chou P. Interrelationship between insulin resistance and menopause on the metabolic syndrome and its individual component among nondiabetic women in the Kinmen study. Am J Med Sci 2007;333:208–14
   PubMed Web of Science ®Google Scholar
• Folsom AR, Kushi LH, Anderson KE, Associations of general and abdominal obesity with multiple health outcomes in older women: the Iowa Women’s Health Study. Arch Intern Med 2000;160:2117–28
   PubMed Web of Science ®Google Scholar
• Tchernof A, Poehlman ET. Effects of the menopause transition on body fatness and body fat distribution. Obes Res 1998;6:246–54
   PubMedGoogle Scholar
• Salpeter SR, Walsh JM, Ormiston TM, Greyber E, Buckley NS, Salpeter EE. Meta-analysis: effect of hormone-replacement therapy on components of the metabolic syndrome in postmenopausal women. Diabetes Obes Metab 2006;8:538–54
   PubMed Web of Science ®Google Scholar
• Pines A, Sturdee DW, Birkhauser MH, Schneider HP, Gambacciani M, Panay N. IMS updated recommendations on postmenopausal hormone therapy. Climacteric 2007;10:181–94
   PubMed Web of Science ®Google Scholar
• Festa A, D’Agostino R Jr, Howard G, Mykkanen L, Tracy RP, Haffner SM. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 2000;102:42–7
   PubMed Web of Science ®Google Scholar
• Senn JJ, Klover PJ, Nowak IA, Mooney RA. Interleukin-6 induces cellular insulin resistance in hepatocytes. Diabetes 2002;51:3391–9
   PubMed Web of Science ®Google Scholar
• Lagathu C, Bastard JP, Auclair M, Maachi M, Capeau J, Caron M. Chronic interleukin-6 (IL-6) treatment increased IL-6 secretion and induced insulin resistance in adipocyte: prevention by rosiglitazone. Biochem Biophys Res Commun 2003;311:372–9
   PubMed Web of Science ®Google Scholar
• Liu S, Tinker L, Song Y, A prospective study of inflammatory cytokines and diabetes mellitus in a multiethnic cohort of postmenopausal women. Arch Intern Med 2007;167:1676–85
   PubMed Web of Science ®Google Scholar
• Stefan N, Vozarova B, Funahashi T, Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans. Diabetes 2002;51:1884–8
   PubMed Web of Science ®Google Scholar
• de Lartigue G, de la Serre CB, Espero E, Lee J, Raybould HE. Diet-induced obesity leads to the development of leptin resistance in vagal afferent neurons. Am J Physiol Endocrinol Metab 2011; 301:E187–95
   PubMed Web of Science ®Google Scholar
• Naugler WE, Sakurai T, Kim S, Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science (80- ) 2007;317:121–4
   PubMed Web of Science ®Google Scholar
• Wang YC, Xu GL, Jia WD, Estrogen suppresses metastasis in rat hepatocellular carcinoma through decreasing interleukin-6 and hepatocyte growth factor expression. Inflammation 2011; 35:143–9
   Web of Science ®Google Scholar
• Prieto J. Inflammation, HCC and sex: IL-6 in the centre of the triangle. J Hepatol 2008;48:380–1
   PubMedGoogle Scholar
• Kim OY, Chae JS, Paik JK, Effects of aging and menopause on serum interleukin-6 levels and peripheral blood mononuclear cell cytokine production in healthy nonobese women. Age (Dordr) 2011;34:415–25
   PubMed Web of Science ®Google Scholar
• Ben AS, Jemaa R, Ftouhi B, Relationship of plasma leptin and adiponectin concentrations with menopausal status in Tunisian women. Cytokine 2011;56:338–42
   PubMed Web of Science ®Google Scholar
• Liu MH, Lin YS, Sheu SY, Sun JS. Anti-inflammatory effects of daidzein on primary astroglial cell culture. Nutr Neurosci 2009; 12:123–34
   PubMed Web of Science ®Google Scholar
• Aubertin-Leheudre M, Lord C, Khalil A, Dionne IJ. Isoflavones and clinical cardiovascular risk factors in obese postmenopausal women: a randomized double-blind placebo-controlled trial. J Womens Health (Larchmt) 2008;17:1363–9
   PubMed Web of Science ®Google Scholar
• Rachon D, Vortherms T, Seidlova-Wuttke D, Wuttke W. Effects of dietary equol on body weight gain, intra-abdominal fat accumulation, plasma lipids, and glucose tolerance in ovariectomized Sprague–Dawley rats. Menopause 2007;14:925–32
   PubMed Web of Science ®Google Scholar
• Llaneza P, Inarrea J, Gonzalez C, Alonso A, Arnott I, Ferrer-Barriendos J. Differences in health related quality of life in a sample of Spanish menopausal women with and without obesity. Maturitas 2007;58:387–94
   PubMed Web of Science ®Google Scholar
• Toth MJ, Tchernof A, Sites CK, Poehlman ET. Menopause- related changes in body fat distribution. Ann NY Acad Sci 2000;904:502–6
   PubMed Web of Science ®Google Scholar
• Uesugi T, Toda T, Tsuji K, Ishida H. Comparative study on reduction of bone loss and lipid metabolism abnormality in ovariectomized rats by soy isoflavones, daidzin, genistin, and glycitin. Biol Pharm Bull 2001;24:368–72
   PubMed Web of Science ®Google Scholar
• Babaei P, Mehdizadeh R, Ansar MM, Damirchi A. Effects of ovariectomy and estrogen replacement therapy on visceral adipose tissue and serum adiponectin levels in rats. Menopause Int 2010;16:100–4
   PubMedGoogle Scholar
• Kuiper GG, Lemmen JG, Carlsson B, Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 1998;139:4252–63
   PubMed Web of Science ®Google Scholar
• Nynca A, Jablonska O, Slomczynska M, Petroff BK, Ciereszko RE. Effects of phytoestrogen daidzein and estradiol on steroidogenesis and expression of estrogen receptors in porcine luteinized granulosa cells from large follicles. J Physiol Pharmacol 2009; 60:95–105
   PubMed Web of Science ®Google Scholar
• Jefferson WN, Patisaul HB, Williams C. Reproductive consequences of developmental phytoestrogen exposure. Reproduction 2012;143:247–60
   PubMed Web of Science ®Google Scholar
• Farmakalidis E, Hathcock JN, Murphy PA. Oestrogenic potency of genistin and daidzin in mice. Food Chem Toxicol 1985; 23:741–5
   PubMed Web of Science ®Google Scholar
• Shanle EK, Xu W. Endocrine disrupting chemicals targeting estrogen receptor signaling: identification and mechanisms of action. Chem Res Toxicol 2011;24:6–19
   PubMed Web of Science ®Google Scholar
• Ding QF, Hayashi T, Zhang XJ, Risks of CHD identified by different criteria of metabolic syndrome and related changes of adipocytokines in elderly postmenopausal women. J Diabetes Complications 2007;21:315–19
   PubMed Web of Science ®Google Scholar
• Bastard JP, Maachi M, Van Nhieu JT, Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro. J Clin Endocrinol Metab 2002;87:2084–9
   PubMed Web of Science ®Google Scholar
• Takahashi M, Funahashi T, Shimomura I, Miyaoka K, Matsuzawa Y. Plasma leptin levels and body fat distribution. Horm Metab Res 1996;28:751–2
   PubMed Web of Science ®Google Scholar
• Charles C, Yuskavage J, Carlson O, Effects of high-dose isoflavones on metabolic and inflammatory markers in healthy postmenopausal women. Menopause 2009;16:395–400
   PubMed Web of Science ®Google Scholar